Costs of outpatient parenteral antimicrobial therapy (OPAT) administered by Hospital at Home units in Spain.
Int J Antimicrob Agents
; 50(1): 114-118, 2017 Jul.
Article
em En
| MEDLINE
| ID: mdl-28499957
ABSTRACT
The aim of this study was to assess the direct healthcare costs of outpatient parenteral antimicrobial therapy (OPAT) administered by Hospital at Home (HaH) units in Spain. An observational, multicentre, economic evaluation of retrospective cohorts was conducted. Patients were treated at home by the HaH units of three Spanish hospitals between January 2012 and December 2013. From the cost accounting of HaH OPAT (staff, pharmacy, transportation, diagnostic tests and structural), the cost of each outpatient course was obtained following a top-down strategy based on the use of resources. Costs associated with inpatient stay, if any, were estimated based on length of stay and ICD-9-CM diagnosis. There were 1324 HaH episodes in 1190 patients (median age 70 years). The median (interquartile range) stay at home was 10 days (7-15 days). Of the OPAT episodes, 91.5% resulted in cure or improvement on completion of intravenous therapy. The mean total cost of each infectious episode was 6707 [95% confidence interval (CI) 6189-7406]. The mean cost per OPAT episode was 1356 (95% CI 1247-1560), mainly distributed between healthcare staff costs (46%) and pharmacy costs (39%). The mean cost of inpatient hospitalisation of an infectious episode was 4357 (95% CI 3947-4977). The cost per day of inpatient hospitalisation was 519, whilst the cost per day of OPAT was 98, meaning a saving of 81%. This study shows that OPAT administered by HaH units resulted in lower costs compared with inpatient care in Spain.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Doenças Transmissíveis
/
Custos de Cuidados de Saúde
/
Administração Intravenosa
/
Assistência Ambulatorial
/
Serviços de Assistência Domiciliar
/
Anti-Infecciosos
Tipo de estudo:
Health_economic_evaluation
/
Observational_studies
/
Risk_factors_studies
Limite:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
País/Região como assunto:
Europa
Idioma:
En
Revista:
Int J Antimicrob Agents
Ano de publicação:
2017
Tipo de documento:
Article